REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH)
CUSIP: 76152G100
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 12,805,677
- Total 13F shares
- 1,865,547
- Share change
- -36,634
- Total reported value
- $2,053,000
- Put/Call ratio
- 0%
- Price per share
- $1.10
- Number of holders
- 9
- Value change
- -$115,802
- Number of buys
- 4
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 76152G100?
CUSIP 76152G100 identifies RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 76152G100:
Top shareholders of RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.4%
|
1,200,000
|
$2,952,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
465,508
|
$1,146,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.61%
|
78,075
|
$192,000 | — | 31 Mar 2022 | |
| EMC Capital Management |
13F
|
Company |
0.43%
|
55,078
|
$135,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.24%
|
31,303
|
$77,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.18%
|
22,842
|
$56,000 | — | 31 Mar 2022 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.11%
|
14,000
|
$34,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
12,700
|
$31,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
10,584
|
$26,000 | — | 31 Mar 2022 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.07%
|
9,299
|
$23,000 | — | 31 Mar 2022 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
1,346
|
$3,000 | — | 31 Mar 2022 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.01%
|
659
|
$1,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
440
|
$1,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
347
|
$1,000 | — | 31 Mar 2022 |
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q2 2022
As of 30 Jun 2022,
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,865,547 shares.
The largest 9 holders included
TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, EMC Capital Management, RAYMOND JAMES & ASSOCIATES, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, and Tower Research Capital LLC (TRC).
This page lists
9
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
14
Q2 2022 holders
9
Holder diff
-5
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.